Literature DB >> 8331596

Effects of isoprenaline on cytosolic calcium concentrations and on tension in the porcine coronary artery.

M Ushio-Fukai1, S Abe, S Kobayashi, J Nishimura, H Kanaide.   

Abstract

1. Using front-surface fluorometry and fura-2-loaded medial strips of the porcine coronary artery, cytosolic Ca2+ concentration ([Ca2+]i) and tension development were simultaneously monitored in an attempt to determine the mechanisms of vasorelaxation induced by l-isoprenaline (Iso). 2. Iso actively decreased [Ca2+]i of the strips at rest, both in the presence and absence of extracellular Ca2+. 3. In the presence of extracellular Ca2+, depolarization with high-external K+ solution induced an elevation of [Ca2+]i and tension of the rapid increase and sustained, steady-state type; both levels depended on external K+ concentration. When Iso was applied at the time of steady state of high-K(+)-induced [Ca2+]i elevation, there was an initial transient reduction (the first component) followed by a subsequent sustained reduction (the second component) of [Ca2+]i. For a given [Ca2+]i level during high-K+ depolarization, the tension developed in the presence of Iso was smaller than that in its absence. Thus, the [Ca2+]i-tension relationship during the steady state of high-K(+)-induced contraction was shifted to the right by Iso. Pretreatment with ryanodine, a compound which depletes Ca2+ stored in the sarcoplasmic reticulum, abolished the first component, but not the second sustained decrease in [Ca2+]i by Iso. 4. In the presence of extracellular Ca2+ (1.25 mM), histamine (Hist) induced an abrupt (the first component) and then sustained (the second component) elevations of [Ca2+]i, while the tension rose rapidly to reach the peak, and then, gradually declined. The second, but not the first, component of [Ca2+]i elevation depended on extracellular Ca2+. Iso inhibited both the first and the second components of [Ca2+]i elevation and the contraction induced by Hist, in a concentration-dependent manner (IC50, 2 x 10(-8) M for the first component, and 5 x 10(-8) M for the second component). Cumulative application of Hist (10(-7)-10(-4) M) increased [Ca2+]i and tension with the [Ca2+]i-tension relationship shifting to the left from that observed with high K+. The [Ca2+]i-tension relationship during the Hist-induced contraction shifted to the right by Iso. In contractions induced by a higher concentration (> or = 6 x 10(-5) M) of Hist, despite the negligible decrease in [Ca2+]i, Iso could relax the muscle in a concentration-dependent manner. 5. In the absence of extracellular Ca2+, Hist induced transient elevations of [Ca2+]i and tension, possibly due to a release of Ca2+ from intracellular stores, and with similar time courses to those of the first component observed in the presence of extracellular Ca2+.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8331596      PMCID: PMC1175322          DOI: 10.1113/jphysiol.1993.sp019576

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  39 in total

1.  Phosphorylation of smooth muscle myosin light chain kinase by the catalytic subunit of adenosine 3': 5'-monophosphate-dependent protein kinase.

Authors:  R S Adelstein; M A Conti; D R Hathaway; C B Klee
Journal:  J Biol Chem       Date:  1978-12-10       Impact factor: 5.157

2.  Role of intracellular Ca2+ sequestration in beta-adrenergic relaxation of a smooth muscle.

Authors:  E Mueller; C van Breemen
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

3.  The action of acetylcholine and catecholamines on an intracellular calcium store in the smooth muscle cells of the guinea-pig taenia coli.

Authors:  R Casteels; L Raeymaekers
Journal:  J Physiol       Date:  1979-09       Impact factor: 5.182

4.  Inhibition of smooth muscle tension by cyclic AMP-dependent protein kinase.

Authors:  W G Kerrick; P E Hoar
Journal:  Nature       Date:  1981-07-16       Impact factor: 49.962

5.  Roles of stored calcium on the mechanical response evoked in smooth muscle cells of the porcine coronary artery.

Authors:  T Itoh; M Kajiwara; K Kitamura; H Kuriyama
Journal:  J Physiol       Date:  1982-01       Impact factor: 5.182

6.  The action of isoprenaline on the smooth muscle of the guinea-pig taenia coli.

Authors:  E Bülbring; A den Hertog
Journal:  J Physiol       Date:  1980-07       Impact factor: 5.182

7.  The effect of histamine on the smooth muscle cells of the ear artery of the rabbit.

Authors:  R Casteels; H Suzuki
Journal:  Pflugers Arch       Date:  1980-08       Impact factor: 3.657

8.  Heparin specifically inhibits the inositol 1,4,5-trisphosphate-induced Ca2+ release from skinned rat aortic smooth muscle cells in primary culture.

Authors:  H Yamamoto; H Kanaide; M Nakamura
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-04       Impact factor: 3.000

9.  Cyclic adenosine monophosphate: potassium-dependent action on vascular smooth muscle membrane potential.

Authors:  A V Somlyo; G Haeusler; A P Somlyo
Journal:  Science       Date:  1970-07-31       Impact factor: 47.728

10.  Effects of acetylcholine and catecholamines on the smooth muscle cell of the porcine coronary artery.

Authors:  Y Ito; K Kitamura; H Kuriyama
Journal:  J Physiol       Date:  1979-09       Impact factor: 5.182

View more
  15 in total

1.  Mechanism of CGRP-induced relaxation in rat intramural coronary arteries.

Authors:  M Sheykhzade; N C Berg Nyborg
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

2.  The mechanism of the decrease in cytosolic Ca2+ concentrations induced by angiotensin II in the high K(+)-depolarized rabbit femoral artery.

Authors:  M Ushio-Fukai; H Yamamoto; J Nishimura; K Hirano; H Kanaide
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

3.  Involvement of Na+-Ca2+ exchanger in cAMP-mediated relaxation in mice aorta: evaluation using transgenic mice.

Authors:  E Karashima; J Nishimura; T Iwamoto; K Hirano; M Hirano; S Kita; M Harada; H Kanaide
Journal:  Br J Pharmacol       Date:  2007-01-15       Impact factor: 8.739

4.  Dorzolamide-induced relaxation of isolated rabbit ciliary arteries mediated by inhibition of extracellular calcium influx.

Authors:  Yaru Dong; Yu Sawada; Jizhe Cui; Masahiro Hayakawa; Dai Ogino; Makoto Ishikawa; Takeshi Yoshitomi
Journal:  Jpn J Ophthalmol       Date:  2016-01-12       Impact factor: 2.447

5.  Effects of Rho-associated protein kinase inhibitors Y-27632 and Y-39983 on isolated rabbit ciliary arteries.

Authors:  Hiroshi Watabe; Sanae Abe; Takeshi Yoshitomi
Journal:  Jpn J Ophthalmol       Date:  2011-06-11       Impact factor: 2.447

6.  The effects of a novel vasodilator, LP-805, on cytosolic Ca2+ concentrations and on tension in rabbit isolated femoral arteries.

Authors:  M Ushio-Fukai; K Hirano; H Kanaide
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

7.  Changes in the cytosolic Ca2+ concentration and Ca(2+)-sensitivity of the contractile apparatus during angiotensin II-induced desensitization in the rabbit femoral artery.

Authors:  M Ushio-Fukai; H Yamamoto; K Toyofuku; J Nishimura; K Hirano; H Kanaide
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

8.  Theophylline attenuates Ca2+ sensitivity and modulates BK channels in porcine tracheal smooth muscle.

Authors:  Shinji Ise; Junji Nishimura; Katsuya Hirano; Nobuyuki Hara; Hideo Kanaide
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

9.  Endothelin-1 and endothelin-3 regulate differently vasoconstrictor responses of smooth muscle of the porcine coronary artery.

Authors:  M Ushio-Fukai; J Nishimura; S Kobayashi; H Kanaide
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

10.  An important role for the Na+-Ca2+ exchanger in the decrease in cytosolic Ca2+ concentration induced by isoprenaline in the porcine coronary artery.

Authors:  Jun Yamanaka; Junji Nishimura; Katsuya Hirano; Hideo Kanaide
Journal:  J Physiol       Date:  2003-05-09       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.